Showing results (211-220 of 1,122) with videos related to
Sort By:
Pageof 113
Expert Opinion on Biological Therapy|February 13, 2018
Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetesMaka S Hedrington, Ana Tsiskarishvili, Stephen N DavisJournal of Virology|November 13, 2009
Viral mutagenesis as a means for generating novel proteinsJohn N Davis, Anthony N van den PolExpert Review of Endocrinology & Metabolism|September 16, 2021
Nocturnal hypoglycemia in type 1 and type 2 diabetes: an update on prevalence, prevention, pathophysiology and patient awarenessMaka Siamashvili, Hugh A Davis, Stephen N DavisClinical Nuclear Medicine|July 1, 1986
Accumulation of technetium-99m MDP in an intramuscular hemangiomaG A Mandell, H T Harcke, N DavisArchives of Neurology|June 1, 1989
Interrater reliability of the NIH stroke scaleL B Goldstein, C Bertels, J N DavisAdvances in Child Development and Behavior|July 25, 2022
Kindness towards all: Prosocial behaviors to address U.S. Latinx youth social inequitiesGustavo Carlo, George P Knight, Alexandra N DavisMatrix Biology Plus|February 5, 2021
In-silico definition of the Drosophila melanogaster matrisomeMartin N Davis, Sally Horne-Badovinac, Alexandra NabaExpert Opinion on Drug Safety|June 1, 2019
An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitorsElizabeth Mary Lamos, Maka Hedrington, Stephen N DavisExpert Opinion on Drug Metabolism & Toxicology|April 28, 2011
Pharmacokinetics, efficacy and safety of aleglitazar for the treatment of type 2 diabetes with high cardiovascular riskLisa M Younk, Lisa Uhl, Stephen N DavisAmerican Journal of Physiology. Endocrinology and Metabolism|October 18, 2007
Antecedent short-term central nervous system administration of estrogen and progesterone alters counterregulatory responses to hypoglycemia in conscious male ratsDarleen A Sandoval, Bin Gong, Stephen N DavisPageof 113